Skip to main content

Table 5 The bivariate metaregression analysis to explore heterogeneity for leucopenia according mean age and line of treatment simultaneously.

From: Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis

Bivariate meta-regression model

Studies characteristics

Leucopenia

 

Res.

Coeff. (CI 95%)

P

Mean age

0%

0.99

(0.96 to 1.01)

0.279

Previous treatment

 

1.59

(0.91 to 2.78)

0.084

  1. The analysis confirms the results of subgroup analysis which indicates that the line of treatment is the best predictor of heterogeneity for severe leucopenia. Coeff. = regression coefficient in exponential form; Res. = residual heterogeneity